213 related articles for article (PubMed ID: 12488992)
1. Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.
Lilova M; Kaplan BS; Meyers KE
Pediatr Nephrol; 2003 Jan; 18(1):57-61. PubMed ID: 12488992
[TBL] [Abstract][Full Text] [Related]
2. Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density.
Saggese G; Baroncelli GI; Bertelloni S; Perri G
J Pediatr; 1995 Sep; 127(3):395-402. PubMed ID: 7658269
[TBL] [Abstract][Full Text] [Related]
3. Long-term growth hormone treatment in short children with CKD does not accelerate decline of renal function: results from the KIGS registry and ESCAPE trial.
Mehls O; Lindberg A; Haffner D; Schaefer F; Wühl E; ;
Pediatr Nephrol; 2015 Dec; 30(12):2145-51. PubMed ID: 26198275
[TBL] [Abstract][Full Text] [Related]
4. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
Seikaly MG; Brown R; Baum M
Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
[TBL] [Abstract][Full Text] [Related]
5. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group.
Fine RN; Kohaut EC; Brown D; Perlman AJ
J Pediatr; 1994 Mar; 124(3):374-82. PubMed ID: 8120705
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.
Maxwell H; Nair DR; Dalton RN; Rigden SP; Rees L
Pediatr Nephrol; 1995 Aug; 9(4):458-63. PubMed ID: 7577409
[TBL] [Abstract][Full Text] [Related]
7. The effects of prolonged substitution of recombinant human growth hormone on renal functional reserve in growth hormone-deficient adults.
Riedl M; Hass M; Oberbauer R; Gisinger J; Luger A; Mayer G
J Am Soc Nephrol; 1995 Nov; 6(5):1434-8. PubMed ID: 8589319
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate.
Tönshoff B; Tönshoff C; Mehls O; Pinkowski J; Blum WF; Heinrich U; Stöver B; Gretz N
Eur J Pediatr; 1992 Aug; 151(8):601-7. PubMed ID: 1380459
[TBL] [Abstract][Full Text] [Related]
9. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human growth hormone treatment in infants with chronic renal failure.
Maxwell H; Rees L
Arch Dis Child; 1996 Jan; 74(1):40-3. PubMed ID: 8660044
[TBL] [Abstract][Full Text] [Related]
11. Predictors of growth response to rhGH in short children before and after renal transplantation. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
Wühl E; Haffner D; Tönshoff B; Mehls O
Kidney Int Suppl; 1993 Oct; 43():S76-82. PubMed ID: 8246375
[TBL] [Abstract][Full Text] [Related]
12. Kidney growth and renal functions under the growth hormone replacement therapy in children.
Ece A; Çetinkaya S; Ekşioğlu S; Şenel S; Özkasap S; Giniş T; Sen V; Şahin C
Ren Fail; 2014 May; 36(4):508-13. PubMed ID: 24456095
[TBL] [Abstract][Full Text] [Related]
13. Results of recombinant growth hormone treatment in children with end-stage renal disease on regular hemodialysis.
Youssef DM
Saudi J Kidney Dis Transpl; 2012 Jul; 23(4):755-64. PubMed ID: 22805388
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
15. Kidney Disease Progression in Autosomal Recessive Polycystic Kidney Disease.
Dell KM; Matheson M; Hartung EA; Warady BA; Furth SL;
J Pediatr; 2016 Apr; 171():196-201.e1. PubMed ID: 26831744
[TBL] [Abstract][Full Text] [Related]
16. Reduced insulin sensitivity during growth hormone therapy for short children born small for gestational age.
Cutfield WS; Jackson WE; Jefferies C; Robinson EM; Breier BH; Richards GE; Hofman PL
J Pediatr; 2003 Feb; 142(2):113-6. PubMed ID: 12584529
[TBL] [Abstract][Full Text] [Related]
17. Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment.
Lanes R; Gunczler P; Orta N; Bosquez M; Scovino R; Dominguez L; Esaa S; Weisinger JR
Horm Res; 1996; 46(6):263-8. PubMed ID: 8982736
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human growth hormone on renal function in children with renal transplants.
Maxwell H; Dalton RN; Nair DR; Turner C; Saunders AJ; Rigden SP; Rees L
J Pediatr; 1996 Feb; 128(2):177-83. PubMed ID: 8636808
[TBL] [Abstract][Full Text] [Related]
19. Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) Registry.
Mekahli D; van Stralen KJ; Bonthuis M; Jager KJ; Balat A; Benetti E; Godefroid N; Edvardsson VO; Heaf JG; Jankauskiene A; Kerecuk L; Marinova S; Puteo F; Seeman T; Zurowska A; Pirenne J; Schaefer F; Groothoff JW;
Am J Kidney Dis; 2016 Nov; 68(5):782-788. PubMed ID: 27555106
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human growth hormone improves growth in children receiving glucocorticoid treatment after liver transplantation.
Sarna S; Sipilä I; Rönnholm K; Koistinen R; Holmberg C
J Clin Endocrinol Metab; 1996 Apr; 81(4):1476-82. PubMed ID: 8636354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]